Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Cell Stem Cell. 2012 Feb 3;10(2):137-47. doi: 10.1016/j.stem.2011.12.015.
Although combination antiretroviral therapy can dramatically reduce the circulating viral load in those infected with HIV, replication-competent virus persists. To eliminate the need for indefinite treatment, there is growing interest in creating a functional HIV-resistant immune system through the use of gene-modified hematopoietic stem cells (HSCs). Proof of concept for this approach has been provided in the instance of an HIV-infected adult transplanted with allogeneic stem cells from a donor lacking the HIV coreceptor, CCR5. Here, we review this and other strategies for HSC-based gene therapy for HIV disease.
虽然联合抗逆转录病毒疗法可以显著降低感染 HIV 的人的循环病毒载量，但复制型病毒仍然存在。为了消除对无限期治疗的需求，人们越来越有兴趣通过使用基因修饰的造血干细胞（HSCs）来创建功能性抗 HIV 免疫系统。在接受来自缺乏 HIV 核心受体 CCR5 的供体的同种异体干细胞移植的 HIV 感染成人的情况下，已经为这种方法提供了概念验证。在这里，我们回顾了基于 HSC 的 HIV 疾病基因治疗的这种方法和其他策略。
